tirzepatide compounding update $125 & Semaglutide $99/mo, Compounded GLP-1 (Annual) Compounded Tirzepatide | KEWW Primary

Tirzepatide is a novel medication that acts as a dual GIP and GLP-1 receptor agonist, enhancing the body's natural ability to regulate blood sugar and promote weight loss

You typically start at 2.5 mg weekly and move up to 5 mg, 10 mg, or 15 mg weekly, depending on your response to the medication and tolerance of side effects

CVS Caremark (Aetna's PBM) removed Zepbound from standard formularies in July 2025including for OSA [11] Self-funded employers can override this decision and keep Zepbound covered Formulary exception requests are still possible with strong medical documentation To determine your exact coverage, check directly with Aetna

Seek same-day medical advice if you develop signs of infection (spreading redness, warmth, discharge, fever), severe or disproportionate pain, large expanding swelling, or systemic symptoms